Benign Prostatic Hyperplasia and Ischemic Heart DIsease
Status:
Completed
Trial end date:
2017-09-01
Target enrollment:
Participant gender:
Summary
To examine the dynamics of 24 - hours ECG monitoring parameters (Holter monitoring) in
patients with ischaemic heart disease (IHD) before and after treatment of voiding
dysfunctions resulted from benign prostatic hyperplasia (BPH) with the indications for either
conservative or operative treatment.
A total of eighty-three 57-to-81-year-old (mean age 70.4±5.75 years) patients with BPH and
accompanying IHD were examined at the Institute of Urology and Human Reproductive Health and
Clinic of Cardiology of the Sechenov University.
Phase:
Phase 4
Details
Lead Sponsor:
I.M. Sechenov First Moscow State Medical University